Get your Emails warmed up and ready to send
Build sender reputation and reach more inboxes with automated email warmup.
Warm up your emails
Starting at $49/month
Marc Buyse
Founder @CluePoints
Signup · Get unlimited contacts
WORK HISTORY
Founder @CluePoints
San Francisco, CA, US
CluePoints is dedicated to monitoring clinical trial data, using a software based on patented statistical algorithms.
EDUCATION
Université libre de Bruxelles
Eng, Engineering
Cranfield School of Management
MBA
Harvard T.H. Chan School of Public Health
ScD, Biostatistics
SKILLS
ABOUT MARC BUYSE
Marc Buyse is the founder of the International Drug Development Institute (IDDI), CluePoints and One2Treat, three companies offering biostatistical services in Europe and the US. He is also Associate Professor of Biostatistics at Universiteit Hasselt in Belgium. He holds degrees in engineering and statistics from Brussels University (ULB), management from the Cranfield School of Management (Cranfield, UK) and biostatistics from Harvard University (Boston, MA). He was President of the International Society for Clinical Biostatistics, President of the Quetelet Society, and Fellow of the Society for Clinical Trials. He worked at the EORTC (European Organization for Research and Treatment of Cancer) in Brussels and at the Dana Farber Cancer Institute in Boston prior to founding IDDI in 1991, CluePoints in 2012 and One2Treat in 2024.Specialties: See Marc\'s publications at: http://publicationslist.org/marc.buyse.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.